Cantor Fitzgerald Reiterates “Overweight” Rating for Surgery Partners (NASDAQ:SGRY)

Cantor Fitzgerald restated their overweight rating on shares of Surgery Partners (NASDAQ:SGRY) in a research report report published on Tuesday morning, Benzinga reports. The firm currently has a $43.00 target price on the stock.

A number of other equities research analysts have also recently commented on the stock. Benchmark reiterated a buy rating and set a $50.00 price target on shares of Surgery Partners in a report on Wednesday, May 1st. Citigroup cut their price target on shares of Surgery Partners from $42.00 to $38.00 and set a buy rating on the stock in a report on Wednesday, May 8th. Macquarie started coverage on shares of Surgery Partners in a report on Friday, June 28th. They issued an outperform rating and a $31.00 target price on the stock. Finally, StockNews.com upgraded shares of Surgery Partners from a sell rating to a hold rating in a report on Thursday, March 21st. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Surgery Partners presently has a consensus rating of Moderate Buy and an average price target of $40.14.

Surgery Partners Trading Up 8.7 %

NASDAQ:SGRY opened at $25.55 on Tuesday. The company’s 50 day moving average price is $25.26 and its 200-day moving average price is $28.33. Surgery Partners has a 52 week low of $22.05 and a 52 week high of $44.88. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 0.92. The stock has a market cap of $3.25 billion, a price-to-earnings ratio of 27.34, a PEG ratio of 1.78 and a beta of 2.78.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. Surgery Partners had a net margin of 0.02% and a return on equity of 3.65%. The firm had revenue of $717.40 million for the quarter, compared to analysts’ expectations of $707.66 million. On average, equities research analysts forecast that Surgery Partners will post 0.88 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Surgery Partners news, insider Danielle Burkhalter sold 6,000 shares of the stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $26.39, for a total value of $158,340.00. Following the transaction, the insider now directly owns 30,354 shares in the company, valued at $801,042.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 2.30% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. Wesbanco Bank Inc. raised its position in Surgery Partners by 53.4% in the second quarter. Wesbanco Bank Inc. now owns 39,363 shares of the company’s stock worth $936,000 after acquiring an additional 13,700 shares during the period. DekaBank Deutsche Girozentrale raised its position in shares of Surgery Partners by 102.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after purchasing an additional 1,375 shares during the period. Janus Henderson Group PLC raised its position in shares of Surgery Partners by 7,987.1% during the 1st quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock valued at $74,701,000 after purchasing an additional 2,473,282 shares during the period. Bamco Inc. NY raised its position in shares of Surgery Partners by 100.0% during the 1st quarter. Bamco Inc. NY now owns 90,000 shares of the company’s stock valued at $2,685,000 after purchasing an additional 45,000 shares during the period. Finally, Magnetar Financial LLC raised its position in shares of Surgery Partners by 511.7% during the 1st quarter. Magnetar Financial LLC now owns 165,466 shares of the company’s stock valued at $4,936,000 after purchasing an additional 138,415 shares during the period.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.